Implementation of a robot for the preparation of antineoplastic drugs in the Pharmacy Service

Objective: To describe the implementation of a robot for the preparation of antineoplastic drugs in the Pharmacy Service and to be able to analyze the added value to pharmacotherapy. Methods: The implementation was carried out in June 2012 at a tertiary level Hospital, taking place in two periods:...

Full description

Bibliographic Details
Main Authors: María de la Paz Pacheco Ramos, Ainhoa Elisa Arenaza Peña, Alejandro Santiago Pérez, Cristina Bilbao Gómez-Martino, María Dolores Zamora Barrios, María Lourdes Arias Fernández
Format: Article
Language:English
Published: Grupo Aula Médica 2015-01-01
Series:Farmacia Hospitalaria
Subjects:
Online Access:http://www.aulamedica.es/fh/pdf/7497.pdf
id doaj-15499e96fdf244279f39cec1e8d345f6
record_format Article
spelling doaj-15499e96fdf244279f39cec1e8d345f62020-11-25T01:57:41ZengGrupo Aula MédicaFarmacia Hospitalaria1130-63432171-86952015-01-0139313714610.7399/fh.2015.39.3.7497Implementation of a robot for the preparation of antineoplastic drugs in the Pharmacy ServiceMaría de la Paz Pacheco Ramos0Ainhoa Elisa Arenaza Peña1Alejandro Santiago Pérez2Cristina Bilbao Gómez-Martino3María Dolores Zamora Barrios4María Lourdes Arias Fernández5Facultativo Adjunto Especialista del Área de Farmacia Hospitalaria. Hospital Facultativo Adjunto Especialista del Área de Farmacia Hospitalaria. Hospital Facultativo Adjunto Especialista del Área de Farmacia Hospitalaria. Hospital Residente de Farmacia Hospitalaria. Hospital Clínico San Carlos. Madrid.Facultativo Adjunto Especialista del Área de Farmacia Hospitalaria. Hospital Jefe de Servicio de Farmacia Hospitalaria. Hospital Clínico San Carlos. Madrid. Objective: To describe the implementation of a robot for the preparation of antineoplastic drugs in the Pharmacy Service and to be able to analyze the added value to pharmacotherapy. Methods: The implementation was carried out in June 2012 at a tertiary level Hospital, taking place in two periods: 1- test period with the installation of the robot, with technical configuration of the equipment and validation of 29 active ingredients and the integration of electronic prescribing software with the robot application (9 months). 2- Usage period (22 months). On the other hand, training was given to pharmacists and nurses. The robot uses image recognition, barcode identification and gravimetric controls for proper operation. These checks provide information about the error ratio in the preparation, with a margin of ± 10%, which after a pilot study was restricted to a range of ±4%. The robot was programmed to recognize bags, infusion pumps, syringes and vials. The added value was assessed for 31 months by identifying preparation´s errors. Results: 11,865 preparations were made by the robot, which meant approximately 40% of all antineoplastic prepared from 29 different active ingredients. 1.12% (n=133) of the errors were identified by the robot and therefore didn´t reach the patient (negative desviation - 4%). These errors were corrected manually. Conclusion: The implementation of a robot in the preparation of antineoplastic drugs allows to identify errors therefore preventing them to arrive to the patient. This promotes safety and quality of the process, reducing the exposure to cytotoxic drugs from the manipulator http://www.aulamedica.es/fh/pdf/7497.pdfRoboticsAntineoplastic; Automation; Development; Production; Safety; Quality
collection DOAJ
language English
format Article
sources DOAJ
author María de la Paz Pacheco Ramos
Ainhoa Elisa Arenaza Peña
Alejandro Santiago Pérez
Cristina Bilbao Gómez-Martino
María Dolores Zamora Barrios
María Lourdes Arias Fernández
spellingShingle María de la Paz Pacheco Ramos
Ainhoa Elisa Arenaza Peña
Alejandro Santiago Pérez
Cristina Bilbao Gómez-Martino
María Dolores Zamora Barrios
María Lourdes Arias Fernández
Implementation of a robot for the preparation of antineoplastic drugs in the Pharmacy Service
Farmacia Hospitalaria
Robotics
Antineoplastic
; Automation
; Development; Production
; Safety; Quality
author_facet María de la Paz Pacheco Ramos
Ainhoa Elisa Arenaza Peña
Alejandro Santiago Pérez
Cristina Bilbao Gómez-Martino
María Dolores Zamora Barrios
María Lourdes Arias Fernández
author_sort María de la Paz Pacheco Ramos
title Implementation of a robot for the preparation of antineoplastic drugs in the Pharmacy Service
title_short Implementation of a robot for the preparation of antineoplastic drugs in the Pharmacy Service
title_full Implementation of a robot for the preparation of antineoplastic drugs in the Pharmacy Service
title_fullStr Implementation of a robot for the preparation of antineoplastic drugs in the Pharmacy Service
title_full_unstemmed Implementation of a robot for the preparation of antineoplastic drugs in the Pharmacy Service
title_sort implementation of a robot for the preparation of antineoplastic drugs in the pharmacy service
publisher Grupo Aula Médica
series Farmacia Hospitalaria
issn 1130-6343
2171-8695
publishDate 2015-01-01
description Objective: To describe the implementation of a robot for the preparation of antineoplastic drugs in the Pharmacy Service and to be able to analyze the added value to pharmacotherapy. Methods: The implementation was carried out in June 2012 at a tertiary level Hospital, taking place in two periods: 1- test period with the installation of the robot, with technical configuration of the equipment and validation of 29 active ingredients and the integration of electronic prescribing software with the robot application (9 months). 2- Usage period (22 months). On the other hand, training was given to pharmacists and nurses. The robot uses image recognition, barcode identification and gravimetric controls for proper operation. These checks provide information about the error ratio in the preparation, with a margin of ± 10%, which after a pilot study was restricted to a range of ±4%. The robot was programmed to recognize bags, infusion pumps, syringes and vials. The added value was assessed for 31 months by identifying preparation´s errors. Results: 11,865 preparations were made by the robot, which meant approximately 40% of all antineoplastic prepared from 29 different active ingredients. 1.12% (n=133) of the errors were identified by the robot and therefore didn´t reach the patient (negative desviation - 4%). These errors were corrected manually. Conclusion: The implementation of a robot in the preparation of antineoplastic drugs allows to identify errors therefore preventing them to arrive to the patient. This promotes safety and quality of the process, reducing the exposure to cytotoxic drugs from the manipulator
topic Robotics
Antineoplastic
; Automation
; Development; Production
; Safety; Quality
url http://www.aulamedica.es/fh/pdf/7497.pdf
work_keys_str_mv AT mariadelapazpachecoramos implementationofarobotforthepreparationofantineoplasticdrugsinthepharmacyservice
AT ainhoaelisaarenazapena implementationofarobotforthepreparationofantineoplasticdrugsinthepharmacyservice
AT alejandrosantiagoperez implementationofarobotforthepreparationofantineoplasticdrugsinthepharmacyservice
AT cristinabilbaogomezmartino implementationofarobotforthepreparationofantineoplasticdrugsinthepharmacyservice
AT mariadoloreszamorabarrios implementationofarobotforthepreparationofantineoplasticdrugsinthepharmacyservice
AT marialourdesariasfernandez implementationofarobotforthepreparationofantineoplasticdrugsinthepharmacyservice
_version_ 1724973198817099776